Special considerations for elderly patients with head and neck cancer during the <scp>COVID</scp>‐19 pandemic

Sharma, Arun; Crosby, Dana L.

doi:10.1002/hed.26216

Cited by 21 publications

(20 citation statements)

References 16 publications

(22 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Administration of chemotherapy and fractionated radiotherapy, however, requires multiple trips to hospitals. 55 This potentially can expose patients, who already are considered high risk, to SARS-CoV2. Sharma and colleagues stress the importance of making informed decisions, weighing not only the patient, comorbidities, and disease status but also the prevalence of COVID and resource availability when making decisions about preferred options for treatment.…”

Section: Discussionmentioning

confidence: 99%

Coronavirus Disease-19

Baird

Sung

2020

Otolaryngologic Clinics of North America

View full text Add to dashboard Cite

This review explores the changes to practice associated with COVID-19 for providers treating patients with head and neck cancer and laryngeal pathology. The aim of the review is to highlight some of the challenges and considerations associated with treating this patient population during the pandemic. Additionally, it seeks to discuss some of the areas of concern related to ramping up clinical volume.

show abstract

Section: Discussionmentioning

confidence: 99%

Coronavirus Disease-19

Baird

Sung

2020

Otolaryngologic Clinics of North America

View full text Add to dashboard Cite

show abstract

“…Es bestand mehrheitlich Einigkeit darüber, dass die flexible transnasale Endoskopie nur bei Anwendung einer persönlichen Schutzausrüstung sinnvoll durchzuführen sei [6,7] [13].…”

Section: Dieser Und Verschiedenen Anderenunclassified

“…Mehrheitliche Zustimmung fand die Empfehlung palliativer Maßnahmen für Patienten mit fortgeschrittenen Kopf-Hals-Karzinomen und einem ECOG Performance Status von 3 (Bettlägerigkeit mehr als die Hälfte des Tages) und im fortgeschrittenen Alter von mehr als 85 Jahren [ 13 ].…”

unclassified

Besonderheiten in der Behandlung von Patienten mit Kopf-Hals-Karzinomen in Zeiten der COVID-19-Pandemie

Hoffmann

Greve

Laban

et al. 2020

HNO

View full text Add to dashboard Cite

“…The COVID-19 pandemic has affected millions of people in more than 180 regions, and patients diagnosed with cancer, as well as older adults, appear to be particularly vulnerable to the morbidity and mortality associated with COVID-19, meaning that older adults with cancer constitute a particularly high-risk population [3]. Elderly patients with head and neck cancer can be expected to have significantly higher COVID-19 severity and mortality [4]. Although most people infected with SARS-CoV-2 have the potential of recovery, mortality in those who develop severe disease increases with the presence of multimorbidity and with comorbidity in the elderly [5,6].…”

Section: Introductionmentioning

confidence: 99%

Effects of Comorbid Factors on Prognosis of Three Different Geriatric Groups with COVID-19 Diagnosis

Görgülü

Duyan

2020

SN Compr. Clin. Med.

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) is a new zoonotic infectious disease that was first reported to the World Health Organization (WHO) on December 31, 2019, and declared as a pandemic by WHO on March 11, 2020. Due to the increased incidence of multimorbidity in geriatric age groups, COVID-19 disease leads to more severe consequences in the elderly. We aimed to determine the effects of age, comorbidity factors, symptoms, laboratory findings, and radiological results on prognosis by dividing our patients into 3 different geriatric age groups, using a retrospective descriptive analysis method. Patients included in the retrospective study ( n = 483) were divided into the following three different geriatric age groups: young-old (65–74 years), middle-aged (75–84 years), and the oldest-elderly (85 years and over).The length of stay in the intensive care unit of the patients between the ages of 75–84 was higher than the other two groups ( p = 0.013). Mortality rates were lowest in patients aged 65–74 years ( p < 0.001). The rate of ground glass opacity in thorax CT was higher in patients with mortality ( p < 0.001). While the rate of COPD-bronchial asthma was higher in surviving patients ( p = 0.001), malignancy ( p = 0.005) and cerebrovascular disease ( p < 0.001) were higher in patients who died. Patients aged between 75 and 84 (OR: 2.602; 95% CI: 1.306–5.183; p = 0.007) or ≥ 85 (OR: 4.086; 95% CI: 1.687–9.9; p = 0.002) had higher risk for mortality compared to patients aged between 65 and 74. The lowest mortality rates were observed in patients aged 65–74 years. Among the supportive diagnostic methods in 3 different geriatric age groups, PCR positivity has no effect on mortality, while the ground glass opacity on tomography is closely related to the need for intensive care and increased mortality. In patients with COPD-bronchial asthma comorbidity and those with symptoms of fatigue, dry cough, and sore throat, transfer to intensive care and mortality rates were lower, while patients who were transferred to intensive care and who developed mortality had higher malignancy and cerebrovascular disease comorbidities and dyspnea symptoms.

show abstract

Special considerations for elderly patients with head and neck cancer during the COVID‐19 pandemic

Cited by 21 publications

References 16 publications

Coronavirus Disease-19

Coronavirus Disease-19

Besonderheiten in der Behandlung von Patienten mit Kopf-Hals-Karzinomen in Zeiten der COVID-19-Pandemie

Effects of Comorbid Factors on Prognosis of Three Different Geriatric Groups with COVID-19 Diagnosis

Contact Info

Product

Resources

About